Company Description
At LinkDoc, our mission is to make precision medicine and personalized care a reality by uncovering the story of every patient journey through the power of data and artificial intelligence.
We have successfully built China’s largest data-driven digital infrastructure for precision medicine, according to Frost & Sullivan, which consists of LinkCare, a digital continuous care platform for patients with critical diseases, LinkData, an AI-enabled curation system for longitudinal medical data, and LinkSolutions, a data-driven precision life sciences solution platform that helps life sciences companies accelerate clinical research and real-world evidence adoption.
These three subsystems interact with one another to form an innovative data-driven digital infrastructure for personalized care and precision medicine with powerful flywheel effects.
We focus on oncology, one of the most complex and aggressive diseases, and we believe by tackling one of the most complicated disease could serve as a good foundation to leverage the experience and apply to other critical diseases.
| Country | China |
| Founded | 2014 |
| Industry | Health Information Services |
| Sector | Technology |
| Employees | 1,250 |
| CEO | Tianze Zhang |
Contact Details
Address: 11/F Building A, Zhonggang International Square Haidian District, Beijing 100080 China | |
| Phone | +86 010-6268 0809 |
Stock Details
| Ticker Symbol | LDOC |
| Exchange | NASDAQ |
| Reporting Currency | USD |
| CIK Code | 0001854384 |
| SIC Code | 7374 |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 11, 2022 | RW | Filing |
| Jul 7, 2021 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Jul 7, 2021 | CERT | Certification by an exchange approving securities for listing |
| Jul 1, 2021 | 8-A12B | Registration of securities |
| Jul 1, 2021 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Jun 30, 2021 | F-6 | Filing |
| Jun 14, 2021 | F-1 | Registration statement for certain foreign private issuers |
| May 13, 2021 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Apr 8, 2021 | DRS | [Cover] Draft Registration Statement |